Literature DB >> 15986372

Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis.

Stefania Viola1, Enrico Felici, Silvia Magni-Manzoni, Angela Pistorio, Antonella Buoncompagni, Nicolino Ruperto, Federica Rossi, Manuela Bartoli, Alberto Martini, Angelo Ravelli.   

Abstract

OBJECTIVE: To develop and validate a clinical measure of articular and extraarticular damage in patients with juvenile idiopathic arthritis (JIA).
METHODS: The Juvenile Arthritis Damage Index (JADI), which is derived from physical examination and a brief review of the patient's clinical history, is composed of 2 parts: assessments of articular damage (JADI-A) and extraarticular damage (JADI-E). Instrument validation was accomplished by evaluating 158 JIA patients with disease duration of at least 5 years, seen consecutively over 21 months. The instrument's feasibility, face and content validity, construct and discriminative ability, internal consistency, and interrater reliability were examined.
RESULTS: Among the 158 JIA patients, 47% and 37% had articular and extraarticular damage, respectively. The JADI was found to be feasible and to possess both face and content validity. The JADI-A score correlated highly with the number of joints with limited range of motion (Spearman's r [r(S)] = 0.72) and correlated moderately with the Childhood Health Assessment Questionnaire score (r(S) = 0.41), Steinbrocker functional classification (r(S) = 0.50), and Poznanski's score of radiographic damage (r(S) = -0.54), thereby demonstrating good construct validity. Correlations with the JADI-E score were lower, owing to the heterogeneity of its items. The JADI-A discriminated well among different levels of disability. The internal consistency (Chronbach's alpha) of the JADI-A and JADI-E was 0.93 and 0.59, respectively. The intraclass correlation coefficients between pairs of independent observers ranged from 0.85 to 0.97.
CONCLUSION: The JADI exhibited good reliability, construct validity, and discriminative ability and is therefore a valid instrument for the assessment of long-term damage in patients with JIA, in the context of both clinical management and research settings.

Entities:  

Mesh:

Year:  2005        PMID: 15986372     DOI: 10.1002/art.21119

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  39 in total

Review 1.  Update on the medical treatment of juvenile idiopathic arthritis.

Authors:  Philip J Hashkes; Ronald M Laxer
Journal:  Curr Rheumatol Rep       Date:  2006-12       Impact factor: 4.592

Review 2.  Outcome Scores in Pediatric Rheumatology.

Authors:  Gabriella Giancane; Silvia Rosina; Alessandro Consolaro; Nicolino Ruperto
Journal:  Curr Rheumatol Rep       Date:  2021-03-08       Impact factor: 4.592

3.  Comparison of clinical, serological, and prognostic differences among juvenile-, adult-, and late-onset lupus nephritis in Korean patients.

Authors:  Ji-Hyoun Kang; Dong-Jin Park; Kyung-Eun Lee; Ji Shin Lee; Yoo-Duk Choi; Shin-Seok Lee
Journal:  Clin Rheumatol       Date:  2017-04-25       Impact factor: 2.980

4.  Serum S100A12 and temporomandibular joint magnetic resonance imaging in juvenile idiopathic arthritis Egyptian patients: a case control study.

Authors:  Ola A Abdul-Aziez; Nayera Z Saber; Samah A El-Bakry; Ahmed A Mohammad; Sahar S Abdel-Maksud; Yaser Ali
Journal:  Pak J Biol Sci       Date:  2010-02-01

5.  High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.

Authors:  Mikel Alberdi-Saugstrup; Marek Zak; Susan Nielsen; Troels Herlin; Ellen Nordal; Lillemor Berntson; Anders Fasth; Marite Rygg
Journal:  Rheumatol Int       Date:  2017-03-10       Impact factor: 2.631

6.  Tumor necrosis factor-α -308 A/G gene polymorphism in children with juvenile idiopathic arthritis: relation to disease activity, damage, and functional status.

Authors:  Iman I El Gazzar; Hanan M Fathy; Tamer A Gheita; Abeer M Nour El-Din; Enas Abdel Rasheed; Rasha H Bassyouni; Sanaa A Kenawy
Journal:  Clin Rheumatol       Date:  2017-06-07       Impact factor: 2.980

7.  Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis.

Authors:  Ayşenur Paç Kısaarslan; Betül Sözeri; Zübeyde Gündüz; Gökmen Zararsız; Hakan Poyrazoğlu; Ruhan Düşünsel
Journal:  Eur J Rheumatol       Date:  2019-04-22

8.  Articular damage in adults with juvenile idiopathic arthritis.

Authors:  Eda Gurcay; Emel Eksioglu; Serdil Yuzer; Ajda Bal; Aytul Cakci
Journal:  Rheumatol Int       Date:  2008-10-14       Impact factor: 2.631

9.  Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).

Authors:  Joanna Lipinska; Stanislawa Lipinska; Marek Kasielski; Elzbieta Smolewska
Journal:  Clin Rheumatol       Date:  2016-07-25       Impact factor: 2.980

10.  Physical disability, articular, and extra-articular damage in patients with juvenile idiopathic arthritis.

Authors:  Pradip Kumar Sarma; Ramnath Misra; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2008-05-24       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.